Assessing the Integration of Tobacco Cessation Treatment Into Lung Cancer Screening (LCS)

• Status: Recruiting
• Trial end date: 2023-02-01
• Target enrollment: 0
• Participant gender: All

Summary

This randomized controlled trial seeks to evaluate the effectiveness of alternative strategies to integrate smoking cessation interventions into the delivery of low-dose CT (LDCT) lung cancer screening. Using a factorial design, current smokers who enroll will be randomly assigned to receive these interventions: (1) smoking cessation counseling support by telephone or videoconferencing (short duration vs. long duration); (2) nicotine patch treatment (NRT) (short vs.long duration); (3) counselor-facilitated referral (vs. no referral) to an online resource to connect smokers to a community-based social service resources.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Massachusetts General Hospital
• Treatments: Nicotine

Criteria

Inclusion Criteria:

• Scheduled to undergo LDCT-LCS at a participating Mass General Brigham Health Care System LCS site

• Speak English or Spanish.

• Current smokers: smoked a cigarette, even a puff, in the last 30 days.

• Medicare coverage requirement (age 50-80 years, 20+ pack/years).

• Residing within the USA.

Exclusion Criteria:

• Undergoing lung CT as part of a diagnostic or abnormal follow-up evaluation.

• Unable to give informed consent due to psychiatric or cognitive impairment as determined in consultation with study PI or treating clinician.

• No access to a telephone or cannot communicate by telephone.